Macleods Pharma Recalls 3,744 Bottles of Blood Pressure Meds Over Dissolution Failures
The FDA has classified a nationwide recall of over 3,700 bottles of a generic triple-combination blood pressure medication as Class II. Manufactured by Macleods Pharma USA, the affected lots failed dissolution testing, meaning the pills may not release active ingredients properly. Patients are advised to check lot numbers and consult their doctors before stopping treatment.